FBR Capital maintains a 'Market Perform' on Amedisys (AMED); 2011 Starts Off Slow, But Should Improve Quickly
Tweet Send to a Friend
FBR Capital maintains a 'Market Perform' on Amedisys (NASDAQ: AMED), PT increased by $4 to $35.
FBR analyst says, "Amedisys ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FBR analyst says, "Amedisys ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
